Skip to content
Search AI Powered

Latest Stories

Pharmacy First Service specification and clinical pathways published

The new service will include seven conditions, alongside the current elements of the Community Pharmacist Consultation Service (CPCS)

NHS England has published the service specification for the Pharmacy First service, which is due to commence at the end of January 2024, following an agreement with the Department of Health and Social Care (DHSC) and Community Pharmacy England (CPE).


It has also released the clinical pathways for the seven conditions which will be included in the service.

The Pharmacy First Service also includes the previous Community Pharmacist Consultation Service (CPCS), which cover minor illness consultations and urgent medicine supply, for people referred to the pharmacy.

“The service enables the management of seven common infections by community pharmacists through offering self-care and safety-netting advice, and, only if appropriate, supplying certain NHS-funded over the counter medicines and prescription only medicines (POMs) via Clinical Protocol and patient group directions (PGDs).

“Patients may access this service either by referral (as for CPCS) or when they are identified as suitable by the pharmacist providing self-care as an essential service,” NHSE stated.

Requirements for Pharmacy First service provision

Pharmacy contractors are required to notify NHS England that they intend to provide the advanced service by completing an electronic registration declaration through the NHS Business Services Authority (NHSBSA) Manage Your Service (MYS) portal.

It is also essential to ensure that they are “satisfactorily complying with their obligations under Schedule 4 of the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations (Terms of Service of NHS pharmacists) in respect of the provision of essential services and an acceptable system of clinical governance.”

An NHS assured Pharmacy First IT system must be used by contractors, and they should refer to the NHS CPCS IT Buyers Guide when choosing an IT supplier.

The pharmacy contractor should include this service in their business continuity plan, and create a standard operating procedure, ensuring that all its staff involved in the service delivery are familiar with and adhere to the SOP.

Both the SOP and the business continuity plan should be reviewed regularly, and whenever there is any significant incident or change to the service, the NHS said.

For the provision of the service, pharmacies must have a consultation room that has IT equipment accessibility to allow contemporaneous records of the consultations provided.

The service should be made available throughout the pharmacy’s full opening hours, and if the service must be temporarily withdrawn, they must inform the NHS Directory of Services (DoS) Provider and Commissioner Helpline (0300 0200 363) as soon as possible.

The Pharmacy First service pathway has three elements: Urgent medicine supply (referral only), Minor illness referral (referral only), and Clinical Pathways consultations (referral and suitable patients identified by the contractor)

Patients may be referred to Pharmacy First by: NHS 111 telephony and on-line, an integrated urgent care clinical assessment service (IUC CAS), 999 services, general practice, and other urgent and emergency care provider such as UTC, ED, or UCC.

Clinical Pathways Consultations

As mentioned by the NHS, clinical pathways are to be used for patients presenting with symptoms potentially associated with any of these seven conditions:

  1. Uncomplicated urinary tract infections (UTIs) in women
  2. Shingles
  3. Impetigo
  4. Infected insect bites
  5. Sinusitis
  6. Sore throat
  7. Acute otitis media

Before making a clinical decision to supply an NHS medicine, the pharmacist must “confirm allergy status and identify any concurrent medication or medical conditions, which may affect the treatment of the patient.”

Payment to the pharmacy contractors providing this service will be made according to arrangements set out within the Drug Tariff.

If the pharmacy contractor wants to permanently stop providing the service, they must notify NHS England via the MYS portal, giving at least one month’s notice period.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less